Douglas M. Brown
Nessuna posizione attualmente
Profilo
Douglas M.
Brown worked as a Senior Managing Director at Leerink Partners LLC from 2015 to 2020 and as the Chief Strategy & Corporate Development Officer at NeoGenomics, Inc. from 2020 to 2022.
He received an undergraduate degree from The University of Texas at Austin and an MBA from The Fuqua School of Business.
Precedenti posizioni note di Douglas M. Brown
Società | Posizione | Fine |
---|---|---|
NEOGENOMICS, INC. | Corporate Officer/Principal | 27/05/2022 |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Corporate Officer/Principal | 01/01/2020 |
Formazione di Douglas M. Brown
The University of Texas at Austin | Undergraduate Degree |
The Fuqua School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NEOGENOMICS, INC. | Health Services |
Aziende private | 1 |
---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
- Borsa valori
- Insiders
- Douglas M. Brown